Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Samuel T Henderson email, Janet L Vogel email, Linda J Barr email, Fiona Garvin email, Julie J Jones email and Lauren C Costantini email

Nutrition & Metabolism 2009, 6:31doi:10.1186/1743-7075-6-31

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.